1-3 of 3
Markus Loeffler, MD, PhD
Close
Sort by
Journal Articles

The Clinical Impact of the Cell-of-Origin Classification and the MYC+/BCL2+ Double Expresser Status in DLBCL Treated within Prospective Clinical Trials of the Dshnhl

Annette M. Staiger, PhD, Marita Ziepert, Heike Horn, PhD, David W. Scott, Thomas F. E. Barth, MD, Heinz-Wolfram Bernd, MD, Alfred C. Feller, MD, Wolfram Klapper, MD, Michael Hummel, Harald Stein, MD PhD, Dido Lenze, Martin-Leo Hansmann, MD, Sylvia Hartmann, MD, Peter Moeller, MD, Sergio Cogliatti, MD, Georg Lenz, MD, Lorenz H. Truemper, MD PhD, Markus Loeffler, MD PhD, Norbert Schmitz, MD, PhD, Michael Pfreundschuh, MD, Andreas Rosenwald, MD, German Ott
Journal: Blood
Blood (2016) 128 (22): 151.
https://doi.org/10.1182/blood.V128.22.151.151
Published: 2016
Journal Articles

Dynamical Modeling of Clonal Evolution in Paired Primary and Relapsed Follicular Lymphoma Predicts a Link Between Cell Migration and Evolutionary Heterogeneity

Matthias Horn, PhD, Markus Kreuz, PhD, Ralf Küppers, PhD, Markus Loeffler, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2929.
https://doi.org/10.1182/blood.V128.22.2929.2929
Published: 2016
Journal Articles

Modeling BCR-ABL Transcript Dynamics in CML Patients under Imatinib Treatment.

Ingo Roeder, PhD, Matthias Horn, Ingmar Glauche, Andreas Hochhaus, MD, Martin C. Mueller, MD, Markus Loeffler, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2155.
https://doi.org/10.1182/blood.V108.11.2155.2155
Published: 2006